Dianthus Therapeutics, Inc. (DNTH)
40.87
-1.05
(-2.50%)
USD |
NASDAQ |
Dec 16, 10:34
Dianthus Therapeutics EPS Diluted (Quarterly): -0.9728 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Cytokinetics, Inc. | -2.552 |
| Lexicon Pharmaceuticals, Inc. | -0.0351 |
| Day One Biopharmaceuticals, Inc. | -0.1908 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.76M |
| Revenue (Quarterly) | 0.396M |
| Total Expenses (Quarterly) | 37.16M |
| Enterprise Value | 1.396B |
| Gross Profit Margin (Quarterly) | 75.00% |
| Profit Margin (Quarterly) | -9.28K% |
| Earnings Yield | -8.54% |
| Normalized Earnings Yield | -8.544 |